Two techniques originally developed for measurement of glycated("glycosylated") hemoglobin but alsoapplicable to determination ofglycatedalbuminare the thiobarbituric acid colorimetric technique(I)and the aminophenylboronic acid affinity chromatographicprocedure (II). The latter reliably distinguishes diabeticsfrom nondiabetics, and concentrationsof glycated hemoglobin and glycatedalbumin are linearly correlated. Iisnonspecific; itneither correlates with diabetic statusnor withvaluesderivedviathe affinity technique. Most of the chromogenic material is present in the fraction of albumin that does not bind to aminophenylboronic acid.Glucose interferes significantly withI but onlyslightly withII. Prolongedincubation ofplasma withglucosedramatically increasesthe Il-determined glycatedalbumin.Reactivity withthiobarbituric acid increases much less, and mainly in theIl-bound fraction. Thisfraction containsa highproportion of nonspecifically reactive material. The percentageof glycated albumin determined in crude plasma samples by II differs onlyslightly fromthevaluedeterminedby purifying the albumin from the plasma. This technique appears more promisingthan Iforeventualclinical applications.
Glucose can irreversibly interact with all body proteins, a process called glycation. Because of the differential electrophoretic mobility of one subfraction of glycated hemoglobin, HbA1, various assays have been developed (1) forreliably and accurately measuring this protein, which serves as a long-term index of the concentration of glucose in blood, given the 120-day life span of the erythrocyte.
However, glucose in blood also undergoes relatively short-term changes in concentration, for which glycated albumin, with a 14-day half life, provides a better index. Only two of the techniques for measuring glycated hemoglobin, the thiobarbituric acid (TBA) colorimetric procedure and aminophenylboronic acid affinity chromatography, are suitable for measuring glycated albumin. Although theoretically straightforward (2,3) the TBA technique is cumbersome in practice and it has not become standard clinical procedure. The newer affinity procedure (4, 5), which accurately and reliably measures glycated hemoglobin, is not affected by many potentially interfering substances, including glucose (6). Here we report our assessment of an afilnity-chromatographic technique for determining glycated albumin, as compared with the TBA technique.
Materials and Methods
Blood samples: Specimens were collected by vempuncture into EDTA-containing evacuated blood-collection tubes. To (800 x g, 10 mm) to settle cell debris, we froze the supernates, storing them at -20 #{176}C for as long as a week or at -70 #{176}C for as long as six months before analysis. Plasma samples were similarly centrifuged (800 X g, 10 mm), and the supernates removed, frozen, and stored. We pooled plasma and hemoglobin samples from at least 25 diabetics (glycated hemoglobin >8%) and at least 25 nondiabetic (glycated hemoglobin <8%) patients.
Measurement of glycated hemoglobin:
We determined glycated hemoglobin by affinity chromatography as previously described (6), using 1-mL columns of m-aminophenylboronic acid ("Glycogel"; Pierce Chemical Co., Rockford, IL 61105).
Measurement of glycated albumin:
We mixed 1-mL plasma samples with 4 mL of pH 8.0 wash buffer (per liter, 250 mmol of ammonium acetate, 50 mmol of MgCl2, and 0.2 g of sodium azide) to adjust sample pH and ionic strength. All 5 mL was then applied to the m-aminophenylboronic acid columns that had previously been equilibrated with the wash buffer. After passing the sample through the column and collecting the effluent in a 16 x 150 mm test tube, we passed 15 mL of wash buffer through the column, collecting it in the same test tube. We then eluted the bound plasma protein from the column into a 16 x 100 mm test tube, the eluent being 3 mL of sodium citrate buffer (0.2moIfL, pH 4.5).
We then determined the concentration of albumin in the wash (nonbound) and eluted (bound) 
In vitro glucose incubation:
We incubated plasma at 37 #{176}C
with glucose in a final concentrationof 5 g/L in the presence of sodium azide, 1 g/L., To stop the reaction at appropriate time points,we removed the incubation medium by ultrafiltration, then reconstitutedthe samples in bufferand stored them frozen until assay.
Sodium borohydride incubation:
After incubating samples at 0 #{176}C for30 mm in a 100-foldmolar excess of sodium borohydride over total protein,we removed the borohydride by ultrafiltration, reconstitutedthe samples in wash buffer, and determined the percent glycated albumin and protein.
Statistical analysis:
Statistical significance was determined by analysis of variance or by the Maim-Whitney nonparametric test for variables not expected to be necessarily normally distributed.
Results

In vitro glycosylation of plasma:
When plasma from nondiabetics was incubated for 14 days with glucose, 5 g/L final 
Parallel determination
of TBA reactivity showed a much smaller increase, with a nonlinear course of glycation: the TBA method detected an early rapid increase, followed by a much slower climb to a final value about 60% greater than baseline after the 14 days. Testing the bound and nonbound fractions from the affinity separation for TBA reactivity (Figure 1, right) showed considerable TBA reactivity in the nonbound fractions, suggesting that the aminophenylboronic acid column does not bind all species of glycated proteins. The nonbound fraction showed an early rapid increase in glycation, again followed by a slow climb to Plasma from non-diabetics was incubated with glucose,5 g/L, until ultrafiltration on the days indicated to remove free glucose.Left: percent glycated albumin; total glycated plasma protein (PercentGly PP.). Bass indicateSE (n =6 each). Right:
TBA reactivity (fiuctose equivalents/mL) in the plasma samples (#{149}) and in the non-bound (0) and bound (0) fractions eluted from the column. BarsindicateSE (n = 4 each) about 60% over baseline; results for the bound fraction by the TBA procedure generally paralleled those by affinity chromatography.
Glucose interactingwith protein forms freely reversible aldimine linkages,which then undergo Amadori rearrangement to form irreversible ketoamine linkages. To determine whether aldimme groups contributed to the fraction bound to the column, we reduced the samples with sodium borohy- to the irreversible open-chain hexitoyllysine form, which does not react with TBA (9) . Therefore, results for the TBA methods after NaBH4 treatment are used as an index of nonspecific TBA reactivity.
Borohydride reduction of aliquots from the plasma samples incubated with glucose for 0 and 14 days dramatically increased the percentages of glycated albumin and glycated total plasma protein, tripling the values in the day 0 sample (Figure 2, left) . The absolute increase in both analytes was duplicated in the day 14 sample. We conclude that rapidly reversible aldimine linkages are evidently present in much larger concentration in nondiabetic serum than are the ketoamine moieties, but the affinity procedure, under our conditions, does not retain them in the bound fraction unless they are converted to hexitoyllysine groups. The TBA reactivity measured after borohydride treatment was between 60 and 70% of the value for nonborohydride-treated (Figure 2, right) . Furthermore, about 80% of the TBA reactivity of the nonbound fraction was due to material that was not affected by borohydride treatment.
Therefore much of the TBA reactivity of the nonbound fraction was nonspecific, i.e., caused by something other than glycated protein. Because the protein concentration is much greater in the NaBH4-treated bound fraction than in the untreated one, the TBA values both before and after incubation were substantially higher after borohydride treatment.
Characterization of affinity separation:
We measured by affinity chromatography the percentage of glycated albumin in two plasma pools, one from nondiabetics and the other from diabetics phoresis on cellulose acetate showed albumin bands of similar size in the normal and diabetic nonbound fractions. The bound protein, however, showed an albumin peak and a broad globulin peak, mostly in the gamma fraction ( Figure  3 ). The globulin peak in the bound fractions from both diabetic and nondiabetic samples was considerably greater than in corresponding nonbound fractions, reflecting the high glycoprotein content of the globulin fraction. The bound albumin peak was considerably larger for the diabetic plasma than that for the nondiabetic sample. The globulin peaks were similar in the diabetic and nondiabetic samples, presumably due to the high normal glycoprotein content of gamma globulins.
To verify that the percent of glycated albumin in plasma samples did not differ from the results obtained with purified albumin, we compared resultsfor samples processed as described in Materials and Methods with those for samples concentrated and reconstituted with distilled water three times on YM 50 membranes (washed samples), and with those for purified albumin samples from both pools. There was no significant difference in the percentage of glycated albumin obtained with the three different methods of preparation. To rule out the possibility that dye binding could be influenced by glycation of protein or other interfering ligands, we assessed percent glycation in purified albumin by dye binding (bromcresol green, Coomassie Blue) and ultraviolet absorbance; the latter obviously is not affected by glycosylation.
Results for percentage glycation of albumin were identical by all these techniques.
Sequential fractionation of the two pools with 2 mL of wash buffer and 1 mL of the sodium citrate elution buffer, followed by reaction with bromcresol green, Coomassie Brilliant Blue, or TBA showed that the albumin peak was well separated, the absorbance of bromcresol green dropping to zero after the first five aliquots of wash buffer (Figure 4 , left). The bound albumin fraction was completely eluted in the first 3 mL of elution buffer. Separation of total plasma protein was not quite as clean, as shown by Coomassie dye reactivity in the final 2-mL fractions eluted by the wash buffer. Most of the TBA-reactive protein was obviously not bound to the column, and was eluted with the wash buffer.
Similarly, purified albumin from each pool was subjected to sequential fractional chromatography (Figure 4, right) . Again, most of the TBA-reactive material was not bound to the column. The TBA-bound reactivity per milligram of protein of both diabetic and nondiabetic samples was about fourfold greater than in the nonbound fractions, but the total amount of protein in the nonbound fraction was much greater than in the bound fraction. The TBA reactivity of the nonbound fractions of diabetics and non-diabetics was similar, whereas that in the bound fractions was three-to fourfold greater in diabetic samples than in the nondiabetics ( Figure 5 ). The apparent lack of difference in the TBA reactivity of nonbound fractions from diabetics and nondiabetics suggests that plasma from either contains TBAreactive albumin species that were not bound to the column and so did not distinguish between diabetics and nondiabetics, whereas the albumin species bound to the columns did differentiate samples from these two types of subjects.
Plasma samples:
The correlation of the two techniques with state of diabetic control was further evaluated with three different plasma pools, one from non-diabetic patients (glycated hemoglobin 6-8%), one from fairly well-controlled diabetic patients (glycated hemoglobin in the range 8-10%), and one from patients with poorly controlled blood sugar (glycated hemoglobin >13%). As expected, there was an increasing level of affinity-determined percentage of glycated albumin, correlating with the increasing percentage of glycated hemoglobin ( Figure 6 , bottom). There was no apparent relationshipbetween non-bound TBA reactivity and increasing glycated hemoglobin, but TBA reactivity of the bound fractions did increase (Figure 6, top) . Filtration of samples to remove plasma glucose decreased the reactivity of the non-bound fractions, but did not modify the lack of correlation of non-bound TBA with glycated hemoglobin and glycated albumin. The percentage of glycated albumin as determined by the affinity procedure was not affected by filtration, nor was bound TBA reactivity.
We fin-ther studied the strong correlation between diabetic status and values for glycated albumin in a group of 40 individual diabetics, finding a linear correlation (r = 0.85) between glycated albumin and glycated hemoglobin obeying the relationship glycated albumin = 0.38 + 0.28[percent glycated hemoglobin].
Effect of plasma glucose on the affinity procedure: Filtration of plasma samples appeared to negligibly affect the proportion of glycated albumin as determined by the affinity procedure.
To confirm this finding, we obtained pooled plasma from non-diabetic donors from the American Red Cross, which storesits plasma in a solution containing, per liter, 5 g of glucose, 3.69 g of trisodium citrate, and 0.46 mg of citric acid. Citrate is the competing ligand in our elution buffer, so the Red Cross crude plasma sample gave a slightly lower value for glycated albumin and glycated plasma protein than did a comparable non-diabetic pool without glucose storage (Figure 7, top left) , but the total TBA reactivity of the Red Cross pool was much higher than that of the non-diabetic pool ( Figure 7 , top right) because the value for the non-bound fraction was much higher. The Red Cross bound TBA reactivity was lower than that of the nondiabetic bound fraction (Figure 7 , top right). After we washed off the citrate dextrose by ultrafiltration, the Red Cross sample gave ( Figure 7 , bottom left) a somewhat higher percent glycalbumin [1.73 (SE 0.08)%l than the filtered non-diabetic pool [1.32 (SE 0.08)%]. TBA reactivity measured in both the ifitered plasma samples and the first filter effluent (Figure 7 , bottom right) showed a higher value for the Red Cross effluent than the effluent from the nondiabetic pool. The affinity procedure and TBA procedure, carried out on albumin purified from these two pools, showed no difference 
LI.
NORMAL DIABETIC
We conclude that the aminophenylboronic acid affinity procedure has several advantages over the TBA technique for determining glycated albumin. It is simple to perform, requiring a single column separation followed by colorimetry. It shows a simple, linear kinetic time course in following 2 life of albumin is relatively stable, except in coexisting liver failure or nephrotic syndrome. Moreover, because albumin is freely accessible to glucose in the blood whereas hemoglobin is enclosed in the erythrocytes, the effects of changes in erythrocyte permeability to glucose and changes in erythrocyte physiology will affect the concentration of glycated hemoglobin (11,12) but not modify the formation of glycated albumin. Finally, and probably most important, the simple techniques presented here, unlike those of the TBA procedure, are readily amenable to use in the clinical laboratory. Determination of glycated albumin should soon be as routine as that of glycated hemoglobin.
